Lycomerve NT Tablet contains a combination of Pregabalin 75 mg and Nortriptyline 10 mg, formulated to manage neuropathic pain and associated conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its effect by modulating calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances the analgesic effect by inhibiting the reuptake of norepinephrine and serotonin, contributing to pain relief and improving mood disorders often accompanying chronic pain. This combination is particularly effective in treating peripheral neuropathies, postherpetic neuralgia, diabetic neuropathy, and fibromyalgia. Lycomerve NT should be used under medical supervision, with dosage adjustments based on patient response and tolerability. Common side effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac disorders, glaucoma, or renal impairment. Concomitant use with other central nervous system depressants should be monitored to avoid additive sedative effects. Pregnant or breastfeeding women should consult their healthcare provider before use. Lycomerve NT Tablet offers a synergistic approach to neuropathic pain management, improving patient quality of life through effective symptom control.